Estrella Immunopharma CFO Executes Recent Common Stock Purchases
Xu Jiandong, the Chief Financial Officer of Estrella Immunopharma, Inc. (NASDAQ:ESLA), has completed several transactions to acquire additional shares of the company's common stock. These acquisitions, occurring in late 2025, involved both direct and indirect holdings. While these moves represent an increase in insider positioning, the company’s st…